Sales változás Dátum
Acadia Pharmaceuticals USD 231.04M 19.34M 2023-12
Agios Pharmaceuticals USD 7.1M 296K 2023-12
Alnylam Pharmaceuticals USD 439.72M 310.81M 2023-12
Amgen USD 8.2B 1.29B 2023-12
Arrowhead Research USD 3.55M 12.55M 2023-12
BioCryst Pharmaceuticals USD 93.4M 6.66M 2023-12
BioMarin Pharmaceutical USD 646.21M 64.88M 2023-12
Bluebird Bio USD 12.39M 5.5M 2023-09
Incyte USD 1.01B 94.32M 2023-12
Ionis Pharmaceuticals USD 325M 180.79M 2023-12
Moderna USD 2.81B 980M 2023-12
Neurocrine Biosciences USD 515.2M 16.4M 2023-12
Novartis USD 11.78B 316M 2023-12
PTC Therapeutics USD 307.06M 110.48M 2023-12
Regeneron Pharmaceuticals USD 3.43B 71.6M 2023-12
Sangamo BioSciences USD 2.04M 7.36M 2023-12
Sanofi EUR 11.75B 1.26B 2023-12
Sarepta Therapeutics USD 396.78M 64.96M 2023-12
Takeda JPY 1.11T 68.1B 2023-12
Ultragenyx Pharmaceutical USD 127.39M 29.34M 2023-12
Vertex Pharmaceuticals USD 2.52B 34.2M 2023-12
Xencor USD 44.69M 14.48M 2023-12



Alnylam Pharmaceuticals Értékesítés - Az oldal aktuális és múlbeli adatokat, elorejelzéseket, statisztikákat, grafikonokat és a gazdasági naptár adatait tartalmazza - Mar 2024.